Skip to main content

Rosenberg Ellen's Form 4 filing

Amicus Therapeutics, Inc. (FOLD) · filed Jan 4, 2024

Accession no.
0000950170-24-002111
Filed
Jan 4, 2024
Trade date
Jan 2-3, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $426.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rosenberg EllenCIK 0001666380Officer (Chief Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 2, 2024Common StockMOption exerciseAcquired+30,000$5.16+$154,800372,285Direct
Jan 2, 2024Common StockSSaleDisposed−30,000$14.21−$426,300342,285Direct
Jan 2, 2024Common StockAGrant or awardAcquired+63,131$0.00$0405,416Direct
Jan 2, 2024Common StockFTax withholdingDisposed−6,985$14.24−$99,466.4398,431Direct
Jan 3, 2024Common StockFTax withholdingDisposed−15,397$13.53−$208,321.41383,034Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 2, 2024Common StockMOption exerciseDisposed−30,000$0.00$030,000Direct
Jan 2, 2024Common StockAGrant or awardAcquired+108,980$0.00$0108,980Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)